Expanding the armamentarium for metabolic dysfunction-associated steatohepatitis
Source
Lancet gastroenterology & hepatology - ISSN 2468-1253-9:12 (2024) p. 1066-1067
An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD)
Source
Nature Metabolism - ISSN 2522-5812-6:6 (2024) p. 1178-1196
Metabolic dysfunction-associated fibrosis 5 (MAF-5) score predicts liver fibrosis risk and outcome in the general population with metabolic dysfunction
Source
Gastroenterology - ISSN 0016-5085-167:2 (2024) p. 1-20
Ferroptosis is a targetable detrimental factor in metabolic dysfunction-associated steatotic liver disease
Source
Cell death and differentiation - ISSN 1350-9047-31 (2024) p. 1113-1126
MASLD/MASH and type 2 diabetes : two sides of the same coin? From single PPAR to pan-PPAR agonists
Source
Diabetes research and clinical practice - ISSN 0168-8227-212 (2024) p. 1-11